Process Development Scientists are responsible for designing and optimizing the processes used to manufacture pharmaceutical products at scale. Their work bridges the gap between laboratory research and large-scale production, ensuring that drugs can be produced efficiently, safely, and cost-effectively. These scientists focus on optimizing formulations, refining production techniques, and improving the consistency and quality of drug products. Their expertise is crucial in identifying the most efficient methods to scale up production without compromising product integrity or regulatory compliance. They also focus on improving the reproducibility of processes, ensuring that every batch produced meets the same high standards of quality and safety. In addition, process development scientists evaluate new technologies and techniques, such as continuous manufacturing and automation, to increase productivity and reduce manufacturing costs. Their work is key to reducing the time-to-market for new drugs, making therapies available to patients more quickly and efficiently.
They work closely with engineers and other technical experts to develop processes that can be replicated in large manufacturing facilities. Process development scientists also play a key role in troubleshooting production issues and ensuring that production processes remain adaptable to meet evolving industry needs and regulations. By optimizing manufacturing protocols, these scientists help streamline the drug development process, reduce production costs, and ensure timely delivery of medications to the market. Their contributions are essential in bringing innovative pharmaceutical therapies to patients worldwide.
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami School of Medicine, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Tailored cellular environments to enable drug design
Lan Wang, Paretor LLC, United States
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : A NAMs-compatible mechanopharmacological model of drug penetration in the urinary bladder
Kunal Sharma, Swisss Federal Institute of Technology Lausanne, Switzerland
Title : Application of quality by design for pulmonary liposomes: Preliminary study to nano in-microparticle
Lucas Amaral Machado, University of Sao Paulo State – UNESP, Brazil
Title : Integrated Raman, SERS and computational approaches for the study of bioactive molecules in pharmaceutical chemistry
Maria Cristina Gamberini, University of Modena and Reggio Emilia, Italy
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, University of Alberta, Canada